Major histocompatibility complex class I-restricted alloreactive CD4+ T cells

被引:28
作者
Boyle, LH [1 ]
Goodall, JC [1 ]
Gaston, JSH [1 ]
机构
[1] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England
关键词
antigen presentation; CD4(+) T cells; human studies; MHC class I;
D O I
10.1111/j.1365-2567.2004.01857.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Although it is well established that CD4(+) T cells generally recognize major histocompatibility complex (MHC) class II molecules, MHC class l-reactive CD4(+) T cells have occasionally been reported. Here we describe the isolation and characterization of six MHC class I-reactive CD4(+) T-cell lines, obtained by co-culture of CD4(+) peripheral blood T cells with the MHC class II-negative, transporter associated with antigen processing (TAP)-negative cell line, T2, transfected with human leucocyte antigen (HLA)-B27. Responses were inhibited by the MHC class I-specific monoclonal antibody (mAb), W6/32, demonstrating the direct recognition of MHC class I molecules. In four cases, the restriction element was positively identified as HLA-A2, as responses by these clones were completely inhibited by MA2.1, an HLA-A2-specific mAb. Interestingly, three of the CD4(+) T-cell lines only responded to cells expressing HLA-B27, irrespective of their restricting allele, implicating HLA-B27 as a possible source of peptides presented by the stimulatory MHC class I alleles. In addition, these CD4(+) MHC class I alloreactive T-cell lines could recognize TAP-deficient cells and therefore may have particular clinical relevance to situations where the expression of TAP molecules is decreased, such as viral infection and transformation of cells.
引用
收藏
页码:54 / 63
页数:10
相关论文
共 57 条
[1]
The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP [J].
Ahn, K ;
Gruhler, A ;
Galocha, B ;
Jones, TR ;
Wiertz, EJHJ ;
Ploegh, HL ;
Peterson, PA ;
Yang, Y ;
Fruh, K .
IMMUNITY, 1997, 6 (05) :613-621
[2]
Cutting edge: Leukocyte receptor complex-encoded immunomodulatory receptors show differing specificity for alternative HLA-B27 structures [J].
Allen, RL ;
Raine, T ;
Haude, A ;
Trowsdale, J ;
Wilson, MJ .
JOURNAL OF IMMUNOLOGY, 2001, 167 (10) :5543-5547
[3]
Allen RL, 1999, J IMMUNOL, V162, P5045
[4]
Isolation of tumor-specific cytotoxic CD4+ and CD4+CCD8dim+ T-cell clones infiltrating a cutaneous T-cell lymphoma [J].
Bagot, M ;
Echchakir, H ;
Mami-Chouaib, F ;
Delfau-Larue, MH ;
Charue, D ;
Bernheim, A ;
Chouaib, S ;
Boumsell, L ;
Bensussan, A .
BLOOD, 1998, 91 (11) :4331-4341
[5]
A SUBSET OF CD4(+) THYMOCYTES SELECTED BY MHC CLASS-I MOLECULES [J].
BENDELAC, A ;
KILLEEN, N ;
LITTMAN, DR ;
SCHWARTZ, RH .
SCIENCE, 1994, 263 (5154) :1774-1778
[6]
Bot A, 1998, J IMMUNOL, V160, P4500
[7]
The recognition of HLA-B27 by human CD4+ T lymphocytes [J].
Boyle, LH ;
Goodall, JC ;
Opat, SS ;
Gaston, JSH .
JOURNAL OF IMMUNOLOGY, 2001, 167 (05) :2619-2624
[8]
Breban M, 1996, J IMMUNOL, V156, P794
[9]
BREWERTON DA, 1973, LANCET, V1, P904
[10]
A functionally defective allele of TAP1 results in loss of MHC class I antigen presentation in a human lung cancer [J].
Chen, HL ;
Gabrilovich, D ;
Tampe, R ;
Girgis, KR ;
Nadaf, S ;
Carbone, DP .
NATURE GENETICS, 1996, 13 (02) :210-213